|
Patient experienced post-injection on-set rash on the opposite side of the knee injection site.A request for additional information including the patient's medical history, allergies, relevant medications, prior injections, indication for durolane, patient status, medical interventions or treatments, and injection technique from the prescribing healthcare provider has been initiated for investigation and medical assessment of the event.
|
|
Patient experienced post-injection on-set rash on the opposite side of the knee injection site.A request for additional information including the patient's medical history, allergies, relevant medications, prior injections, indication for durolane, patient status, medical interventions or treatments, and injection technique from the prescribing healthcare provider has been initiated for investigation and medical assessment of the event.\
\
no additional information has been received for the investigation.\
\
the medical assessment of the reported rash is not impetigo, a highly contagious bacterial skin infection which may or may not manifest with blisters.Although the clinical information is very limited (including, but not limited to, the lack of a biopsy results, if one was performed), the clinical appearance of the cutaneous lesion is consistent with ischemic skin necrosis consistent with nicolau syndrome, a rare complication of hyaluronic acid injections.While nicolau syndrome remains a plausible explanation for the observed findings, the atypical anatomical distribution and limited supporting clinical information preclude a definitive diagnosis.In this case, the event of presumed nicolau syndrome following durolane injection is reasonably concluded to have been caused or may have been caused or contributed to by the device (durolane).\
\
although intraarticular visco supplementation is intended to be injected into the joint space, not in any soft tissue structure, inadvertent direct injury to and/or injection of material into the underlying skin vessels has been known to occur with visco supplementation.
|